352 related articles for article (PubMed ID: 12540386)
21. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
22. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
Chan DC; Watts GF; Barrett PH; Martins IJ; James AP; Mamo JC; Mori TA; Redgrave TG
J Lipid Res; 2002 May; 43(5):706-12. PubMed ID: 11971941
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790
[TBL] [Abstract][Full Text] [Related]
24. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.
Westphal S; Orth M; Ambrosch A; Osmundsen K; Luley C
Am J Clin Nutr; 2000 Apr; 71(4):914-20. PubMed ID: 10731497
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
26. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
27. Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
Chan DC; Watts GF; Barrett PH; Beilin LJ; Redgrave TG; Mori TA
Diabetes; 2002 Aug; 51(8):2377-86. PubMed ID: 12145148
[TBL] [Abstract][Full Text] [Related]
28. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
29. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance.
Park Y; Harris WS
J Lipid Res; 2003 Mar; 44(3):455-63. PubMed ID: 12562865
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E enrichment of immuno-separated chylomicron and chylomicron remnants following saturated fatty acids.
Jackson KG; Wolstencroft EJ; Bateman PA; Yaqoob P; Williams CM
Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):405-17. PubMed ID: 16935699
[TBL] [Abstract][Full Text] [Related]
31. The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL.
Fisher WR; Zech LA; Bardalaye P; Warmke G; Berman M
J Lipid Res; 1980 Aug; 21(6):760-74. PubMed ID: 7419987
[TBL] [Abstract][Full Text] [Related]
32. Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
Hazzard WR; Kushwaha RS; Applebaum-Bowden D; Haffner SM; Steinmetz A; Foster DM
Metabolism; 1984 Oct; 33(10):873-81. PubMed ID: 6482732
[TBL] [Abstract][Full Text] [Related]
33. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
Meyer BJ; Hammervold T; Rustan AC; Howe PR
Lipids; 2007 Mar; 42(2):109-15. PubMed ID: 17393216
[TBL] [Abstract][Full Text] [Related]
34. Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.
Dallongeville J; Boulet L; Davignon J; Lussier-Cacan S
Arterioscler Thromb; 1991; 11(4):864-71. PubMed ID: 2065040
[TBL] [Abstract][Full Text] [Related]
35. Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells.
van Greevenbroek MM; van Meer G; Erkelens DW; de Bruin TW
Atherosclerosis; 1996 Mar; 121(1):139-50. PubMed ID: 8678919
[TBL] [Abstract][Full Text] [Related]
36. ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia.
Chan DC; Pang J; Barrett PH; Sullivan DR; Burnett JR; van Bockxmeer FM; Watts GF
J Clin Endocrinol Metab; 2016 Oct; 101(10):3732-3739. PubMed ID: 27490922
[TBL] [Abstract][Full Text] [Related]
37. The hyperenergetic-fed obese dog, a model of disturbance of apolipoprotein B-100 metabolism associated with insulin resistance: kinetic study using stable isotopes.
Briand F; Bailhache E; Andre A; Magot T; Krempf M; Nguyen P; Ouguerram K
Metabolism; 2008 Jul; 57(7):966-72. PubMed ID: 18555839
[TBL] [Abstract][Full Text] [Related]
38. The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects.
de Roos B; Caslake MJ; Stalenhoef AF; Bedford D; Demacker PN; Katan MB; Packard CJ
Am J Clin Nutr; 2001 Jan; 73(1):45-52. PubMed ID: 11124749
[TBL] [Abstract][Full Text] [Related]
39. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.
Pont F; Duvillard L; Florentin E; Gambert P; Vergès B
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1726-32. PubMed ID: 12377756
[TBL] [Abstract][Full Text] [Related]
40. Effect of n-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects.
Ouguerram K; Maugeais C; Gardette J; Magot T; Krempf M
Br J Nutr; 2006 Jul; 96(1):100-6. PubMed ID: 16869997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
